531210 — Colinz Laboratories Balance Sheet
0.000.00%
- IN₹106.15m
- IN₹38.55m
- IN₹65.28m
- 75
- 48
- 13
- 41
Annual balance sheet for Colinz Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PRESS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 46.8 | 52.1 | 57.3 | 70 | 55.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13 | 12.1 | 11.3 | 8.59 | 6.61 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 72.7 | 73.8 | 78.4 | 87.4 | 90.2 |
| Net Property, Plant And Equipment | 20.3 | 18.6 | 17.1 | 15.8 | 17 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 101 | 99.3 | 102 | 114 | 118 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25.9 | 19.8 | 18.9 | 21.8 | 21.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 28.1 | 22.4 | 20.9 | 24.1 | 23.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 72.9 | 76.9 | 81.4 | 89.5 | 94.7 |
| Total Liabilities & Shareholders' Equity | 101 | 99.3 | 102 | 114 | 118 |
| Total Common Shares Outstanding |